Works matching DE "MELANOMA immunotherapy"

Results: 102

By what way Physician can Enhance Outcomes in Patients with Metastatic Malignant Melanoma.

Published in:

International Journal of Hematology-Oncology & Stem Cell Research, 2012, v. 6, n. 1, p. 13

By:

Payandeh, Mehrdad;
Aeinfar, Mehrnoush;
Maleki, Ali;
Erfan Zare, Mohammad

Publication type:

Article

Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 4339, doi. 10.2147/OTT.S136194

By:

Moucheng Zhang;
Zhilong Yan;
Junjiang Wang;
Xueqing Yao

Publication type:

Article

Immunotherapy in Metastatic Melanoma: Better Alone or in Combination?

Published in:

Cancer & Chemotherapy Reviews, 2016, v. 11, n. 2, p. 39

By:

de la Rosa, Carlos Aguado;
Puente-Vázquez, Javier

Publication type:

Article

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.

Published in:

Nature Medicine, 2015, v. 21, n. 1, p. 81, doi. 10.1038/nm.3773

By:

Linnemann, Carsten;
van Buuren, Marit M;
Bies, Laura;
Verdegaal, Els M E;
Schotte, Remko;
Calis, Jorg J A;
Behjati, Sam;
Velds, Arno;
Hilkmann, Henk;
Atmioui, Dris el;
Visser, Marten;
Stratton, Michael R;
Haanen, John B A G;
Spits, Hergen;
van der Burg, Sjoerd H;
Schumacher, Ton N M

Publication type:

Article

Cancer immunotherapy shows promise in multiple tumor types.

Published in:

Nature Medicine, 2012, v. 18, n. 7, p. 993, doi. 10.1038/nm0712-993

By:

Heger, Monica

Publication type:

Article

Immunohistochemical analysis of O-methylguanine-DNA methyltransferase in human melanoma in comparison with skin squamous cell carcinoma.

Published in:

Medical Molecular Morphology, 2014, v. 47, n. 1, p. 8, doi. 10.1007/s00795-013-0030-3

By:

Kokunai, Yasuhito;
Tsuji, Motomu;
Ito, Yuko;
Kurokawa, Teruo;
Otsuki, Yoshinori;
Moriwaki, Shinichi

Publication type:

Article

A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1359, doi. 10.1007/s00262-017-2030-y

By:

Patel, Sapna;
Kim, Dae;
Bassett, Roland;
Cain, Suzanne;
Washington, Edwina;
Hwu, Wen-Jen;
Kim, Kevin;
Papadopoulos, Nicholas;
Homsi, Jade;
Hwu, Patrick;
Bedikian, Agop

Publication type:

Article

Selective effect of cytokine-induced killer cells on survival of patients with early-stage melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 299, doi. 10.1007/s00262-016-1939-x

By:

Li, Hong;
Huang, Lan;
Liu, Linbo;
Wang, Ximei;
Zhang, Zhen;
Yue, Dongli;
He, Wei;
Fu, Kun;
Guo, Xueli;
Huang, Jianmin;
Zhao, Xuan;
Zhu, Yu;
Wang, Liping;
Dong, Wenjie;
Yan, Yan;
Xu, Li;
Gao, Ming;
Yang, Shuangning;
Zhang, Yi

Publication type:

Article

Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 5, p. 601, doi. 10.1007/s00262-016-1823-8

By:

Contreras, Amanda;
Sen, Siddhartha;
Tatar, Andrew;
Mahvi, David;
Meyers, Justin;
Srinand, Prakrithi;
Suresh, Marulasiddappa;
Cho, Clifford

Publication type:

Article

Increasing radiation dose improves immunotherapy outcome and prolongation of tumor dormancy in a subgroup of mice treated for advanced intracerebral melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 127, doi. 10.1007/s00262-015-1772-7

By:

Smilowitz, Henry;
Micca, Peggy;
Sasso, Daniel;
Wu, Qian;
Dyment, Nathanial;
Xue, Crystal;
Kuo, Lynn

Publication type:

Article

Intratumoral immunotherapy for melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 911, doi. 10.1007/s00262-015-1727-z

By:

Singh, Manisha;
Overwijk, Willem

Publication type:

Article

Broadening the repertoire of melanoma-associated T-cell epitopes.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 609, doi. 10.1007/s00262-015-1664-x

By:

Frøsig, Thomas;
Lyngaa, Rikke;
Met, Özcan;
Larsen, Stine;
Donia, Marco;
Svane, Inge;
thor Straten, Per;
Hadrup, Sine

Publication type:

Article

Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 381, doi. 10.1007/s00262-014-1642-8

By:

Wilgenhof, Sofie;
Corthals, Jurgen;
Nuffel, An;
Benteyn, Daphné;
Heirman, Carlo;
Bonehill, Aude;
Thielemans, Kris;
Neyns, Bart

Publication type:

Article

Armed antibodies for cancer treatment: a promising tool in a changing era.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 113, doi. 10.1007/s00262-014-1621-0

By:

Danielli, Riccardo;
Patuzzo, Roberto;
Ruffini, Pier;
Maurichi, Andrea;
Giovannoni, Leonardo;
Elia, Giuliano;
Neri, Dario;
Santinami, Mario

Publication type:

Article

Fast-growing in-transit melanoma metastasis after intratumoral interleukin-2.

Published in:

2014

By:

Moreno-Ramírez, David;
Alés-Martínez, Martina;
Ferrándiz, Lara

Publication type:

Letter

Limited efficacy of intratumoral IL-2 applied to large melanoma metastases.

Published in:

2014

By:

Weide, Benjamin;
Eigentler, Thomas;
Elia, Giuliano;
Neri, Dario;
Garbe, Claus

Publication type:

Letter

Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 959, doi. 10.1007/s00262-014-1558-3

By:

Van Lint, Sandra;
Wilgenhof, Sofie;
Heirman, Carlo;
Corthals, Jurgen;
Breckpot, Karine;
Bonehill, Aude;
Neyns, Bart;
Thielemans, Kris

Publication type:

Article

Therapy model for advanced intracerebral B16 mouse melanoma using radiation therapy combined with immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 7, p. 1187, doi. 10.1007/s00262-013-1423-9

By:

Smilowitz, Henry;
Sasso, Daniel;
Lee, Edward;
Goh, Gyuhyeong;
Micca, Peggy;
Dilmanian, F.

Publication type:

Article

An immune-active tumor microenvironment favors clinical response to ipilimumab.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1019, doi. 10.1007/s00262-011-1172-6

By:

Ji, Rui-Ru;
Chasalow, Scott;
Wang, Lisu;
Hamid, Omid;
Schmidt, Henrik;
Cogswell, John;
Alaparthy, Suresh;
Berman, David;
Jure-Kunkel, Maria;
Siemers, Nathan;
Jackson, Jeffrey;
Shahabi, Vafa

Publication type:

Article

Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1033, doi. 10.1007/s00262-011-1176-2

By:

Nuffel, An;
Benteyn, Daphné;
Wilgenhof, Sofie;
Corthals, Jurgen;
Heirman, Carlo;
Neyns, Bart;
Thielemans, Kris;
Bonehill, Aude

Publication type:

Article

Quantitative Characterization of the Exposure-Response Relationship for Cancer Immunotherapy: A Case Study of Nivolumab in Patients With Advanced Melanoma.

Published in:

2017

By:

Wang, X;
Feng, Y;
Bajaj, G;
Gupta, M;
Agrawal, S;
Yang, A;
Park, J‐S;
Lestini, B;
Roy, A

Publication type:

Case Study

Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 1, p. 5, doi. 10.1002/psp4.12131

By:

de Greef, R;
Elassaiss‐Schaap, J;
Chatterjee, M;
Turner, DC;
Ahamadi, M;
Forman, M;
Cutler, D;
de Alwis, DP;
Kondic, A;
Stone, J

Publication type:

Article

A One Health overview, facilitating advances in comparative medicine and translational research.

Published in:

2016

By:

Stroud, Cheryl;
Dmitriev, Igor;
Kashentseva, Elena;
Bryan, Jeffrey;
Curiel, David;
Rindt, Hans;
Reinero, Carol;
Henry, Carolyn;
Bergman, Philip;
Mason, Nicola;
Gnanandarajah, Josephine;
Engiles, Julie;
Gray, Falon;
Laughlin, Danielle;
Gaurnier-Hausser, Anita;
Wallecha, Anu;
Huebner, Margie;
Paterson, Yvonne;
O'Connor, Daniel;
Treml, Laura

Publication type:

Abstract

Melanoma Immunotherapy: Next-Generation Biomarkers.

Published in:

Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00178

By:

Hogan, Sabrina A.;
Levesque, Mitchell P.;
Cheng, Phil F.

Publication type:

Article

A Novel miR-451a isomiR, Associated with Amelanotypic Phenotype, Acts as a Tumor Suppressor in Melanoma by Retarding Cell Migration and Invasion.

Published in:

PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107502

By:

Babapoor, Sankhiros;
Fleming, Elizabeth;
Wu, Rong;
Dadras, Soheil S.

Publication type:

Article

HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy.

Published in:

PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0073261

By:

Ma, Juan;
Han, Huamin;
Liu, Deruo;
li, Wei;
Feng, Hongxiang;
Xue, Xin;
Wu, Xiaoran;
Niu, Ge;
Zhang, Ge;
Zhao, Yunfeng;
Liu, Changzhen;
Tao, Hua;
Gao, Bin

Publication type:

Article

Intralesional Injection of Rose Bengal Induces a Systemic Tumor-Specific Immune Response in Murine Models of Melanoma and Breast Cancer.

Published in:

PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068561

By:

Toomey, Paul;
Kodumudi, Krithika;
Weber, Amy;
Kuhn, Lisa;
Moore, Ellen;
Sarnaik, Amod A.;
Pilon-Thomas, Shari

Publication type:

Article

Immune and molecular correlates in melanoma treated with immune checkpoint blockade.

Published in:

2017

By:

Byrne, Elizabeth H.;
Fisher, David E.

Publication type:

journal article

Somatic driver mutations in melanoma.

Published in:

2017

By:

Reddy, Bobby Y.;
Miller, David M.;
Tsao, Hensin

Publication type:

journal article

Molecular insights into melanoma brain metastases.

Published in:

2017

By:

Westphal, Dana;
Glitza Oliva, Isabella C.;
Niessner, Heike

Publication type:

journal article

Interaction of molecular alterations with immune response in melanoma.

Published in:

2017

By:

Szczepaniak Sloane, Robert A.;
Gopalakrishnan, Vancheswaran;
Reddy, Sangeetha M.;
Zhang, Xue;
Reuben, Alexandre;
Wargo, Jennifer A.

Publication type:

journal article

New immunotherapies show promise in some patients: Physicians try to balance optimism with realistic expectations.

Published in:

2015

By:

Printz, Carrie

Publication type:

Other

Highlights from the AACR annual meeting.

Published in:

2014

By:

Printz, Carrie

Publication type:

Proceeding

Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma.

Published in:

2014

By:

Ascierto, Paolo A.;
Margolin, Kim

Publication type:

Editorial

Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors.

Published in:

Cancer (0008543X), 2014, v. 120, n. 11, p. 1695, doi. 10.1002/cncr.28620

By:

Ackerman, Allison;
Klein, Oliver;
McDermott, David F.;
Wang, Wei;
Ibrahim, Nageatte;
Lawrence, Donald P.;
Gunturi, Anasuya;
Flaherty, Keith T.;
Hodi, F. Stephen;
Kefford, Richard;
Menzies, Alexander M.;
Atkins, Michael B.;
Long, Georgina V.;
Sullivan, Ryan J.

Publication type:

Article

American Association of Cancer Research Showcases Immunotherapy Advances.

Published in:

JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 4, doi. 10.1093/jnci/djv231

By:

Brower, Vicki

Publication type:

Article

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma.

Published in:

Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01617

By:

Sadozai, Hassan;
Gruber, Thomas;
Hunger, Robert Emil;
Schenk, Mirjam

Publication type:

Article

Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release.

Published in:

Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01342

By:

Pampena, María B.;
Barrio, María M.;
Juliá, Estefanía P.;
Blanco, Paula A.;
von Euw, Erika M.;
Mordoh, José;
Levy, Estrella Mariel

Publication type:

Article

Clinical utility of nivolumab in the treatment of advanced melanoma.

Published in:

2016

By:

Asmar, Ramsey;
Yang, Jessica;
Carvajal, Richard D

Publication type:

journal article

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response.

Published in:

2017

By:

De Wolf, Katrien;
Kruse, Vibeke;
Sundahl, Nora;
van Gele, Mireille;
Chevolet, Ines;
Speeckaert, Reinhart;
Brochez, Lieve;
Ost, Piet

Publication type:

journal article

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.

Published in:

Scientific Reports, 2015, p. 11198, doi. 10.1038/srep11198

By:

Chang-Hao Tsao, Simon;
Weiss, Jonathan;
Hudson, Christopher;
Christophi, Christopher;
Cebon, Jonathan;
Behren, Andreas;
Dobrovic, Alexander

Publication type:

Article

Update on use of aldesleukin for treatment of high-risk metastatic melanoma.

Published in:

ImmunoTargets & Therapy, 2015, v. 4, p. 79, doi. 10.2147/ITT.S61590

By:

Amaria, Rodabe N.;
Reuben, Alexandre;
Cooper, Zachary A.;
Wargo, Jennifer A.

Publication type:

Article

Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine.

Published in:

2016

By:

Sioud, Mouldy;
Nyakas, Marta;
Sæbøe-Larssen, Stein;
Mobergslien, Anne;
Aamdal, Steinar;
Kvalheim, Gunnar

Publication type:

Case Study

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response.

Published in:

Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/s12967-014-0262-6

By:

Ridolfi, Laura;
de Rosa, Francesco;
Ridolfi, Ruggero;
Gentili, Giorgia;
Valmorri, Linda;
Scarpi, Emanuela;
Parisi, Elisabetta;
Romeo, Antonino;
Guidoboni, Massimo

Publication type:

Article

TCR Gene Transfer:MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets.

Published in:

Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/586314

By:

Straetemans, Trudy;
Van Brakel, Mandy;
Van Steenbergen, Sabine;
Broertjes, Marieke;
Drexhage, Joost;
Hegmans, Joost;
Lambrecht, Bart N.;
Lamers, Cor;
Der Bruggen, Pierre van;
Coulie, Pierre G.;
Debet, Reno

Publication type:

Article

Lessons from Cancer Immunoediting in Cutaneous Melanoma.

Published in:

Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/192719

By:

Aris, Mariana;
Barrio, MaríaMarcela;
Mordoh, José

Publication type:

Article

Targeting the PD-1 pathway: a promising future for the treatment of melanoma.

Published in:

Archives of Dermatological Research, 2014, v. 306, n. 6, p. 511, doi. 10.1007/s00403-014-1457-7

By:

Mamalis, Andrew;
Garcha, Manveer;
Jagdeo, Jared

Publication type:

Article

Quantification of PD-1/PD-L1 Interaction between Membranes from PBMCs and Melanoma Samples Using Cell Membrane Microarray and Time-Resolved Förster Resonance Energy Transfer.

Published in:

Analytica, 2021, v. 2, n. 4, p. 156, doi. 10.3390/analytica2040015

By:

Sánchez-Magraner, Lissete;
de la Fuente, Miguel;
Evans, Charles;
Miles, James;
Elexpe, Ane;
Rodriguez-Astigarraga, Maddalen;
Astigarraga, Egoitz;
Barreda-Gómez, Gabriel

Publication type:

Article

Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.

Published in:

Clinical & Experimental Ophthalmology, 2016, v. 44, n. 6, p. 509, doi. 10.1111/ceo.12688

By:

Goh, Amanda YL;
Layton, Christopher J

Publication type:

Article

Multispectral imaging for highly accurate analysis of tumour-infiltrating lymphocytes in primary melanoma.

Published in:

Histopathology, 2017, v. 70, n. 4, p. 643, doi. 10.1111/his.13070

By:

Vasaturo, Angela;
Di Blasio, Stefania;
Verweij, Dagmar;
Blokx, Willeke A M;
Krieken, J Han;
Vries, I Jolanda M;
Figdor, Carl G

Publication type:

Article